Skip to main content
. 2014 Oct 9;5:503. doi: 10.3389/fmicb.2014.00503

Table 2.

Effect of Toxoplasma gondii infection on hormones in animals.

References Type of study Type of host Age of the host (weeks) Way of infectiona Stage parasite Strainb Number of parasites Days post-infection Analysis techniquec Hormonesd Groupe N Resultsf p
1 Kittas and Henry, 1979 In vivo Guinea-pigs NS SC Cysts Bk 50 42 Number of Toixoplasma cysts ± SD
HIS 17β-estradiol (E2) Control F: 8 88.75 ± 21.60
Control M: 8 82.50 ± 21.1* <0.001
Gdt F: 8 63.00 ± 16.5
Gdt M: 8 65.25 ± 10.8
Gdt + Hex F: 8 200.25 ± 16.00
Gdt + Hex M: 8 184.00 ± 36.80
2 Kittas and Henry, 1980 In vivo Mice 11 SC Cysts Bk 30 42 Number of Toxoplasma cysts ± SD
HIS 17β-estradiol Control F: 8 222 ± 42
(E2) Control M: 8 220 ± 23
Gdt F: 8 189 ± 22* <0.001
Gdt M: 8 178 ± 24* <0.001
Gdt + Hex F: 8 598 ± 64* <0.001
Gdt + Hex M: 8 599 ± 45* <0.001
3 Pung and Luster, 1986 In vivo Mice (B6C3F1) 8–10 SC Cysts T45 30 35 Number of Toxoplasma cysts ± SD
RIA Control 6 982 ± 194
DES 6 2244 ± 66* <0.05
17β-estradiol 6 1934 ± 198* <0.05
5α-Dihydrotesti osterone 6 792 ± 164
Progesterone 6 1012 ± 172
Zeralanol 6 1463 ± 190
a-Dienestrol 6 2405 ± 227* <0.05
Corticosterone 6 1954 ± 314* <0.05
Effect of Tamoxifen, number of cysts ± SD
RIA 17β-estradiol (E2) Control 6 1115 ± 112
Tamoxifen 6 975 ± 124
17β-estradiol 6 2220 ± 182* <0.05
Tamoxifen + E2 6 1027 ± 167
4 Fredriksson et al., 1990 In vivo Ewes (Scottish blackface) NS Oral Oocysts RH 2000 90.5 Progesterone levels (nM/L)
RIA Progesterone (P4) Control 3 10–20
Infected 13 10 NS
Vaccinated 15 10 NS
5 Aiumalamai et al., 1990 In vivo Ewes (Swedish Peltsheep) 52–104 NS Oocysts NS NS 90.5 Progesterone levels (nM/L)
RIA Progesterone (P4) 7 Day 5: 6–8
Days 10 a 15: 19- <0.05
6 Hulínská et al., 1990 In vivo Mice (H VUFB) 4–5 IP Cysts P78 10 Number of tachyzoites and stozoites
5–14 HIS y MIC Cortisone Group 1 20 10–14 days
12–47 Group 2 20
7 Engeland et al., 1996 In vivo Goat (Norwegian) NS SC Bradyzoites NS 1250 54–73 Progesterone levels
ELISA y SF Progesterone (P4) Control 6
Infected 5
8 Stahl and Kaneda, 1998a In vivo Mice (Nya: NYLAR) NS IP Cysts CS 8 3 and 4 T4 levels (Mean)
RIA Thyroxine (T4) Control 10 7.5
Infected 10 3 <0.01
9 Stahl and Kaneda, 1998a In vivo Mice (Nya: NYLAR) 12 IP Cysts CS 8 4 Subnormal T4 response to a 1 |ig bolus or TRH (Mean)
RIA Thyroxine (T4) Control 8 11
Infected 8 3 <0.01
10 Liesenfeld et al., 2001 In vivo Mice (C57BL/6) 8–10 Oral Cysts ME 49 100 7 Number of parasitophorous vacuoles
NS Testosterone Control 657 ± 399
Testosteron 426 ± 282 =0.0141
11 Kaňková et al., 2011 In vivo Mice (BALB/c and C57 Black) 5–6 Oral Cysts T38 10 60 Differences in serum testosterone levels
RIA Testosterone M. Toxo infected 12 Z = −2.32 =0.005
M. Controls 20
F. Toxo infected 12 Z = −2.76 =0.020
F. Controls 20
12 Abdoli et al., 2012 In vivo Rats (Wistar) NS IP Tachyzoites RH 1 × 107 Effect of T. gondii infection on Serum Testosterone (ST)
10 ELISA Testosterone Uninfected 5 0.6 ± 0.01
10 Infected 3 0.55 ± 0.02* <0.05
Effect of T.gondii infection on IntratesticularTestosteron (ITT)
10 Uninfected 5 4.07 ± 0.02
10 Infected 3 3.89 ± 0.05* <0.05
13 Puvanesuaran et al., 2012 In vivo Mice (Swiss) 3 Oral Tachyzoites RH 1 × 104 4 Number of tachyzoites (Mean)
MIC Prednisolone Control 3 1.48 × 107
235 mg/kg 3 2.75 × 107 <0.05
470 mg/kg 3 2.92 × 107 <0.05
705 mg/kg 3 3.21 × 107 <0.05
14 Lim et al., 2013 In vivo Rats (Wistar) 7 IP Tachyzoites PRU 5 × 106 42–56 % Increase of Testosterona levels
ELISA Testosterone 54 60% =0.057
15 Mitra et al., 2013 In vivo Rats 6.5 IP Tachyzoites PRU 10 × 106 42–56 Circuling levels of corticosterone
ELISA Corticosterone 126 64% <0.05
a

SC, Subcutaneously; IP, Intraperitoneally; NA, Not Applicable.

b

Type of strain: BK, Beverley; PRU, Prugniaud; CS, Cornell; RH, ME49, T45, P78, T38.

c

HIS, Histological; RIA, Radioimmunoassay; MIC, Microscopical; SF, Sabin and Feldman; ELISA, Enzyme-Linked ImmunoSorbent Assay.

d

E2, 17β-estradiol; P4, Progesterone; T4, Thyroxine; DES, Diethylstilbestrol; ST, Serum Testosterone; ITT, Intra testicular testosterone; TRH, Thyrotropin-Releasing Hormone.

e

M, Male; F, Female; Gdt, Gonadectomy; Hex, Hexoestrol.

f

, Increased infection; , Decrement infection; ↑, Increased hormone; ↓, Decrement hormone;

*

and bold, Statistically Significant. NS, Not specified; SD, Standard deviation.